![]() |
市場調查報告書
商品編碼
1492500
電腦輔助藥物發現市場:按類型、治療領域和最終用戶分類 - 2024-2030 年全球預測Computer-aided Drug Discovery Market by Type (Ligand-Based Drug Design, Sequence-Based Approaches, Structure-Based Drug Design), Therapeutic Area (Cardiovascular Disease, Diabetes, Neurology), End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2023年電腦輔助藥物發現市場規模預計為37.4億美元,預計2024年將達到40.8億美元,2030年將達到71.6億美元,複合年成長率預計為9.71%。
電腦輔助藥物發現 (CADD) 是生物製藥行業中用於加速和增強候選藥物發現過程的科學技術。 CADD 利用計算方法來模擬和預測藥物與生物標的之間的相互作用。此過程允許在實驗室合成和測試候選藥物之前對其進行識別,從而節省時間和資源。隨著臨床試驗的增加,生物技術和製藥行業的成長正在推動對電腦輔助藥物發現解決方案的需求。 CADD 透過預測候選藥物與其標靶結合或引起副作用的可能性,可以顯著縮短藥物發現時間。這種效率對於縮短上市時間非常有利的產業至關重要。高昂的初始成本和對品質資料的日益依賴阻礙了市場的成長。運算能力的進步和演算法的改進提高了 CADD 的效率和能力,預計將創造市場成長機會。
主要市場統計 | |
---|---|
基準年[2023] | 37.4億美元 |
預測年份 [2024] | 40.8億美元 |
預測年份 [2030] | 71.6億美元 |
複合年成長率(%) | 9.71% |
區域洞察
在美洲,由於對醫療保健技術的大量投資和大型製藥公司的存在,電腦輔助藥物發現市場高度發展。電腦輔助系統廣泛用於加速藥物發現、降低成本、提高開發新藥效率。此外,由於醫療保健支出的增加和製藥業的成長,南美洲國家擴大採用這些技術。由於醫療保健技術投資的增加、製藥公司和研究機構數量的增加,亞太地區的 Research_KEYWORD 市場正在快速成長。中國和印度等國家由於人口眾多且對改善醫療保健的興趣日益濃厚,正在引領市場。該地區受益於先進技術的引進和政府對醫療保健研究的支持力度的加大。歐洲市場強勁,擁有先進的研究設施和對藥物開發的大量投資。歐洲國家在開發支持高效藥物發現過程的先進技術方面擁有強大的立足點。中東和非洲部分地區在採用這些技術方面正在取得進展,儘管速度慢於歐洲。這些地區的成長主要是由醫療保健部門私有化程度的提高以及尋求加強醫療保健基礎設施的國家對新技術的投資所推動的。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在電腦輔助藥物發現市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對電腦輔助藥物發現市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在電腦輔助藥物發現市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[195 Pages Report] The Computer-aided Drug Discovery Market size was estimated at USD 3.74 billion in 2023 and expected to reach USD 4.08 billion in 2024, at a CAGR 9.71% to reach USD 7.16 billion by 2030.
Computer-aided drug discovery (CADD) is a scientific technique used in the biopharmaceutical industry to expedite and enhance the process of discovering new drug candidates. CADD utilizes computational approaches to simulate and predict the interaction between drugs and biological targets. This process can help identify potential new drugs before they are synthesized and tested in the lab, saving time and resources. Growth in the biotechnology and pharmaceutical industries with an increasing number of clinical trials is driving the demand for computer-aided drug discovery solutions. CADD can significantly shorten the drug discovery timeline by predicting how likely a drug candidate is to bind to its target and if it might cause side effects. This efficiency is crucial for industries where reducing time to market can be highly beneficial. High initial costs and rising reliance on quality data hamper the market growth. Rising improvements in computational power and algorithms that enhance the efficiency and capabilities of CADD are expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.74 billion |
Estimated Year [2024] | USD 4.08 billion |
Forecast Year [2030] | USD 7.16 billion |
CAGR (%) | 9.71% |
Regional Insights
In the Americas, the computer-aided drug discovery market is highly developed due to significant investments in healthcare technology and the strong presence of pharmaceutical giants. Computer-aided systems are extensively used to speed up drug discovery, reduce costs, and increase efficiency in developing new drugs. There's also a growing trend in South American countries to adopt these technologies, driven by increasing healthcare expenditures and growing pharmaceutical sectors. The APAC region is witnessing rapid growth in the computer-aided drug discovery market fueled by increasing investment in healthcare technology and a rise in pharmaceutical companies and research institutions. Countries including, China and India are leading the way, given their large populations and increasing focus on healthcare improvements. The region benefits from advanced technology adoption and increased governmental support in healthcare research. The market in Europe is robust, with advanced research facilities and substantial investments in drug development. European countries have a strong foothold in developing advanced technologies that aid in efficient drug discovery processes. The Middle East and parts of Africa are progressively adopting these technologies, although slower than Europe. The growth in these regions is primarily driven by increasing health sector privatization and investments in new technologies by countries aiming to bolster their healthcare infrastructures.
Market Insights
The market dynamics represent an ever-changing landscape of the Computer-aided Drug Discovery Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Computer-aided Drug Discovery Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Computer-aided Drug Discovery Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
MilliporeSigma Introduces AIDDISON: A Pioneering SaaS Platform for Streamlined Drug Development
MilliporeSigma has unveiled AIDDISON, the first software-as-a-service (SaaS) platform that integrates virtual molecule design with practical manufacturability. Leveraging the Synthia retrosynthesis software API, AIDDISON employs generative AI and machine learning within a computer-aided drug design framework. The platform effectively accelerates the drug discovery process by sifting through over 60 billion molecular combinations, pinpointing compounds that exhibit crucial drug attributes including, non-toxicity, solubility, and stability. [Published On: 2023-12-05]
Bayer AG and Google Cloud Partner to Advance Drug Discovery Through Quantum Chemistry
Bayer AG and Google Cloud have announced a strategic partnership aimed at enhancing early-stage drug discovery by utilizing Google Cloud's Tensor Processing Units (TPUs). These custom-built accelerators are designed to manage advanced machine-learning models and demanding computational tasks. This collaboration seeks to significantly improve the speed and scalability of quantum chemistry calculations, which are crucial for in-silico modeling that accurately simulate biological and chemical interactions. [Published On: 2023-01-11]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Computer-aided Drug Discovery Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Computer-aided Drug Discovery Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accelrys, Inc., AstraZeneca PLC, Bayer AG, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Chemical Computing Group Inc., Dassault Systemes SE, Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline PLC, Merck & Co., Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Roche Holding AG, Sanofi S.A., Schrodinger, Inc., Simulations Plus, Inc., and Vertex Pharmaceuticals Incorporated.
Market Segmentation & Coverage